Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial

Steve M Taylor, Sarah Korwa, Angie Wu, Cynthia L Green, Betsy Freedman, Sheila Clapp, Joseph Kipkoech Kirui, Wendy P O’Meara, Festus M Njuguna
doi: https://doi.org/10.1101/2022.08.02.22278335

Article usage

Article usage: August 2022 to December 2024

AbstractFullPdf
Aug 20223731938
Sep 20226216
Oct 20226448
Nov 20224342
Dec 20222737
Jan 20231320
Feb 20231634
Mar 20232923
Apr 20231711
May 20232153
Jun 2023951
Jul 2023523
Aug 202315106
Sep 202320913
Oct 2023830
Nov 20232194
Dec 20231202
Jan 20241412
Feb 20241172
Mar 2024837
Apr 202414156
May 2024510
Jun 2024922
Jul 2024914
Aug 2024855
Sep 20242556
Oct 20241565
Nov 20241213
Dec 20241304
Back to top
Posted August 03, 2022.
Download PDF
Data/Code
Email
Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial
Steve M Taylor, Sarah Korwa, Angie Wu, Cynthia L Green, Betsy Freedman, Sheila Clapp, Joseph Kipkoech Kirui, Wendy P O’Meara, Festus M Njuguna
medRxiv 2022.08.02.22278335; doi: https://doi.org/10.1101/2022.08.02.22278335
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area